Skip to main content
ALLR
NASDAQ Life Sciences

U.S. Patent Granted for Stenoparib DRP® Diagnostic, Securing Exclusivity Until 2042

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.333
Mkt Cap
$20.684M
52W Low
$0.769
52W High
$2.35
52W Position info
73% above low
Off High info
43% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

ALLR sits 73% above its 52-week low of $0.769 on light trading volume (0.4× avg).

Summary

Allarity Therapeutics announced the grant of a key U.S. patent for its stenoparib DRP® companion diagnostic, securing exclusivity until April 2042. This follows the Notice of Allowance from the USPTO, which the company announced in an 8-K filing on April 28th. The patent is a critical step, establishing a long-term intellectual property foundation for stenoparib and its patient-selection approach in ovarian cancer. For a clinical-stage biotech, this significantly de-risks the future commercialization pathway of a lead asset.

At the time of this announcement, ALLR was trading at $1.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.7M. The 52-week trading range was $0.77 to $2.35. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ALLR - Latest Insights

ALLR
Nov 17, 2026, 7:50 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.870
Real-time Price: $0.800 info
Change: -$0.070 (-8%) info
Market Cap: $12.558M info
ALLR
Nov 13, 2026, 8:07 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.800 info
Change: -$0.150 (-16%) info
Market Cap: $12.558M info
ALLR
Nov 13, 2026, 8:05 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.950
Real-time Price: $0.800 info
Change: -$0.150 (-16%) info
Market Cap: $12.558M info
ALLR
Nov 02, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.8415
Real-time Price: $0.800 info
Change: -$0.0415 (-5%) info
Market Cap: $12.558M info
ALLR
Oct 30, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.870
Real-time Price: $0.800 info
Change: -$0.070 (-8%) info
Market Cap: $12.558M info